Stanbury R M, Graham E M
Medical Eye Unit, St Thomas's Hospital, London.
Br J Ophthalmol. 1998 Jun;82(6):704-8. doi: 10.1136/bjo.82.6.704.
The anti-inflammatory effects of corticosteroids cannot be separated from their metabolic effects as all cells use the same glucocorticoid receptor; therefore when corticosteroids are prescribed measures should be taken to minimise their side effects. Clearly, the chance of significant side effects increases with the dose and duration of treatment and so the minimum dose necessary to control the disease should be given. Before embarking on a long term course of corticosteroids the factors summarised in Table 1 should be considered. A full discussion with the patient is necessary in order to explain the benefits and risks of corticosteroid treatment. A patient information leaflet is now provided by the manufacturers of all systemic corticosteroid preparations. As emphasised by the recent publication by the Committee on the Safety of Medicines, advice to patients is the key to the safe use of long term systemic corticosteroids and it recommends discussing the following points with the patient: not to stop taking corticosteroids suddenly to see a doctor if they become unwell of the increased susceptibility to infections, especially chickenpox of the serious side effects that may occur to read and keep the patient information leaflet to always carry the steroid treatment card and to show it to any health professional involved in their treatment. In addition the following suggestions may help to minimise some side effects: a single morning dose early dietary modification--low calorie, low sodium, and high potassium awareness of possible errors of judgment on high doses. Once started on corticosteroids the patient should be regularly reviewed to assess the response to the treatment with adjustments to keep the dose at a minimum.
皮质类固醇的抗炎作用与其代谢作用无法分开,因为所有细胞都使用相同的糖皮质激素受体;因此,在开具皮质类固醇药物时,应采取措施尽量减少其副作用。显然,严重副作用的发生几率会随着治疗剂量和疗程的增加而上升,所以应给予控制疾病所需的最小剂量。在开始长期使用皮质类固醇治疗之前,应考虑表1中总结的因素。必须与患者进行充分讨论,以解释皮质类固醇治疗的益处和风险。现在,所有全身性皮质类固醇制剂的制造商都会提供一份患者信息手册。正如药品安全委员会最近发布的文件所强调的,向患者提供建议是安全使用长期全身性皮质类固醇的关键,该委员会建议与患者讨论以下几点:不要突然停止服用皮质类固醇;如果身体不适要去看医生;注意感染易感性增加,尤其是水痘;了解可能出现的严重副作用;阅读并保存患者信息手册;始终携带类固醇治疗卡,并向参与其治疗的任何医护人员出示。此外,以下建议可能有助于尽量减少一些副作用:早晨单次给药;早期调整饮食——低热量、低钠和高钾;意识到高剂量时可能出现的判断失误。一旦开始使用皮质类固醇,应对患者进行定期复查,以评估治疗反应,并进行调整以使剂量保持在最低水平。